A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Clinical trial NCT05281328 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05281328
- Sponsor
- Camurus AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2025-02-05
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.